
Nanotech strategy shows promise for treating autoimmune disease In a Scripps Research study, a nanoparticle treatment cured' mice that had a genetic arthritis condition.
December 01, 2022
LA JOLLA, CA Scientists at Scripps Research have reported success in initial tests of a new, nanotech-based strategy against autoimmune diseases.
The scientists, who reported their results on November 23, 2022, in the journal ACS Nano, engineered cell-like nanoparticles that target only the immune cells driving an autoimmune reaction, leaving the rest of the immune system intact and healthy. The nanoparticles greatly delayed, and in some animals even prevented, severe disease in a mouse model of arthritis.
The potential advantage of this approach is that it would enable safe, long-term treatment for autoimmune diseases where the immune system attacks its own tissues or organs using a method that won't cause broad immune suppression, as current treatments do, says study senior author James Paulson, PhD, Cecil H. and Ida M. Green Chair of Chemistry in the Department of Molecular Medicine at Scripps Research.
Autoimmune diseases such as rheumatoid arthritis are caused when the immune system mistakenly attacks a person's own tissues or organs. These illnesses affect an estimated 10 million people in the U.S. alone. Treatments are available and can be effective for many patients, but they tend to suppress the immune system indiscriminately, creating an enhanced susceptibility to infections and cancers among other side effects.
Paulson and his team have taken an approach that targets the immune system more narrowly. Many autoimmune diseases are triggered or driven by immune attacks on just one protein in the patient's body, known as a self-antigen. The idea underlying the nanoparticle strategy is to eliminate or deactivate only the immune cells that attack that self-antigen an approach that could be at least as effective as broad immune suppression, without the side effects. Autoimmune diseases that are dominated by immune responses to a single self-antigen include some forms of arthritis, the skin blister disease known as pemphigus and the thyroid ailment Graves' disease.
The researchers, including first author Katarzyna Brzezicka, PhD, a postdoctoral research associate in the Paulson lab, research assistant Britni Arlian, and other lab members, designed nanoparticles that could deactivate two types of immune cells: B cells and T cells. On its surface, each nanoparticle bore copies of a target self-antigen, plus a sugar-related molecule that can bind to a special off switch receptor on B cells called CD22. B cells, which make antibodies and are specific to different antigens, will effectively shut themselves off if they encounter both the particular antigen they target and the binding partner of CD22 at the same time.
Each nanoparticle also was laced with a powerful compound called rapamycin to stimulate the production of immune cells called regulatory T cells. Treg cells, as they're also known, are responsible for suppressing other T cells needed to generate an autoimmune attack. The overall aim of the study was to effectively knock out only the B and T cells that recognize the self-antigen, leaving the rest of the B- and T-cell populations intact.
The researchers first demonstrated that their nanoparticle-based strategy could tolerize the mouse immune system to a chicken protein, ovalbumin, that would otherwise trigger a strong response. Next, they tested the strategy in a widely used mouse model of arthritis, in which the mouse immune system is genetically predisposed to attack a self-antigen called GPI. The scientists showed that treatment of the mice with GPI-tolerizing nanoparticles at the age of three weeks greatly delayed the development of arthritis signs that would normally appear a week or two later. In fact, about a third of the mice remained arthritis-free for the maximum follow-up period of 300 days. Tests confirmed that the treatment dramatically reduced the mice's production of anti-GPI antibodies, and at the same time boosted their Treg populations.
Paulson says his team plans to follow up these highly promising results with further optimization of the nanoparticle strategy.
We were able to cure' a third of these animals in this early demonstration, and I think theres the potential to combine our nanoparticles with other immune modulator treatments to make it even more effective, Paulson says. So that will our next step as well as demonstrating our technology against other autoimmune diseases caused by unwanted immune responses to a self-antigen.
Suppression of Autoimmune Rheumatoid Arthritis with Hybrid Nanoparticles That Induce B and T Cell Tolerance to Self-Antigen was co-authored by Katarzyna Brzezicka, Britni Arlian, Shengyang Wang, Merissa Olmer, Martin Lotz, and James Paulson, all of Scripps Research.
This work was funded in part by the National Institutes of Health (R01AI050143, R01AI132790).
Autoimmune Diseases Immunology & Microbiology Paulson, James
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
19/11/2026
With a sports-bar vibe and all the teams onsite in a huge atrium in Ballpark Vil...
19/11/2026
The senior from Phoenix and England is balancing life as a Division I tennis player with a growing career behind the microphone
The future of live sports produ...
19/11/2026
RED Digital Cinema and Colorfront have partnered to integrate native Colorfront color management into RED Connect, letting productions apply Colorfront's co...
19/11/2026
SMPTE has published an engineering report summarizing an industry survey by its Study Group on Content Provenance and Authenticity in Media. The findings point ...
19/11/2026
CTech and Skyline Communications have announced a partnership to deliver integra...
19/11/2026
Euskal Irrati Telebista (EITB), the Basque Country's public media group, has completed Phase 1 of a five-studio renewal with the commissioning of a Lawo IP ...
19/11/2026
The Esports Foundation (EF) has announced an expanded Road to ENC 2027 for the E...
19/11/2026
All Women's Sports Network (AWSN) held its first awards show, VEON: Women W...
19/11/2026
Gracenote, the content intelligence business unit of Nielsen, has extended its relationship with DIRECTV. Gracenote will continue to supply visual imagery and p...
19/11/2026
The Audio Engineering Society (AES) Technical Committee on Broadcast and Online ...
19/11/2026
NDI has released NDI 6.4, which adds Recording and Playback APIs, support for HEVC 4:4:4 and a configurable receiver buffer for Wi-Fi. The update also includes ...
19/11/2026
Lemonlight, the video production company behind more than 50,000 brand videos, has announced Hero, an AI production operating system, along with a new AI agent ...
19/11/2026
In a first-of-its-kind deployment at XFINITY Center, the digital signage/display...
19/11/2026
For the first time on a US streaming service, real-time player identification, contextual stats, and visual insights appear right in the live stream, available ...
19/11/2026
His career runs from the 2-in. videotape era to Canada's first HD and UHD live-production facilities...
19/11/2026
The popular sports-graphics event features a new Chairperson and new venue...
19/11/2026
Beth de Ara jo, Gemma Chan, Channing Tatum and Mason Reeves attend the premiere of Josephine at Eccles Theatre on January 23, 2026, in Park City, UT. (Photo b...
19/11/2026
New performance-focused brass library announced
Expressive E's latest release brings together four meticulously sampled brass instruments: sousaphone, b...
19/11/2026
Acoustic synthesizer gains free web editor
The phase8 acoustic synthesizer has been an ongoing project for Korg Berlin. It was unveiled as an early prototyp...
19/11/2026
MIDI controller keyboards upgraded
Designed for users who want a full-size keyboard and hands-on DAW control but in a relatively compact footprint, Nektar...
19/11/2026
Hugely popular compact monitor overhauled
IK Multimedia's ultra-compact monitors have proven to be incredibly popular, and the company say that they'...
19/11/2026
Rohde & Schwarz brings company-wide technology and service expertise to critical...
19/11/2026
On October 8, 2026, Nielsen employees came together around the world to celebrate our fourteenth company-wide day of service, Nielsen Global Impact Day (NGID). ...
19/11/2026
Integrating Gracenote's content intelligence with Nexxen's unique CTV supply allows advertisers to more closely align campaigns with audience viewing ha...
19/11/2026
Enhancement Mirrors Local TV's Recent Move to 1-Minute Qualifier (1MQ)
Upda...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , er...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
As Founder and Creative Director of Future Phonic Studios, the Netherlands' first Dolby Atmos music studio, Richard Burki has spent more than a decade pushi...
19/11/2026
Boris FX Black Friday Sale - 25% Off Everything
Brie Clayton November 19, 2026
0 Comments
Check out the Boris FX Black Friday sale on Monday, November...
19/11/2026
Virtual Production Finds Its Middle Ground with Blackmagic Design
Brie Clayton November 19, 2026
0 Comments
How Neon Vision is using PYXIS 12K and Ult...
19/11/2026
FL Studio Announces Black Friday Discounts of Up to 50% Across Its Software Line...
19/11/2026
TBS Drama Series Tagusari Brothers Uses DaVinci Resolve Studio
Brie Clayton November 19, 2026
0 Comments
TBS ACT streamlines post production for broad...
19/11/2026
Beeble launches SwitchX 3.0 with dynamic environments and greater creative contr...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , er...
19/11/2026
Five-year deployment has automated APL's media supply chain from fixture to archive, managing over 200,000 assets
Blue Lucy, the workflow orchestration and...
19/11/2026
Riding the Australian wave through co-pros 11 November 2026
L-R: The Surfer, We Bury the Dead
Australian stories are captivating global audiences and attracti...
19/11/2026
Screen Australia and Australian Film Television and Radio School announce the Fi...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
iStreamU LLC, a rapidly growing production and systems integration company founded by longtime Producer/Director Ivan Gonzalez, has standardized its audio workf...
19/11/2026
LA JOLLA, CA-Clarivate, a global information and analytics company, named seven ...
19/11/2026
Frank Skinner, Judi Love and Richard Ayoade join Kerry Godliman for three outdoor adventures across Dorset, Wales and Norfolk.
Kerry Godliman is swapping comed...
19/11/2026
Thursday 19 November 2026
The Day of the Jackal: Eddie Redmayne returns in firs...
19/11/2026
When I first started my career in lighting engineering, it felt cutting edge and rewarding to be designing solutions that affect all of us every day, whether at...